PARNAX LAB
|
The Current P/E Ratio of PARNAX LAB is 12.90.
| Share Price | ₹123.8 | Feb 09,2026 |
| Market Cap | ₹142.4 Cr | |
| Earnings-TTM | ₹11.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 12.90x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PARNAX LAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹142.4 Cr] as on Feb 09,2026
(/) Earnings [ ₹11.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 12.90x ]
Thus, for PARNAX LAB , the investors are currently willing to pay 12.90 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PARNAX LAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PARNAX LAB over the last five years.
Historical PE (Price/Earnings) ratio chart of PARNAX LAB
PE Ratio Performance Analysis for PARNAX LAB
- PARNAX LAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.75x.
- PARNAX LAB 's operated at median p/e ratio of 10.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 15.68x.
- PARNAX LAB 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does PARNAX LAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PARNAX LAB | 11.04 | 12.90 | 142.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.18 | 408,991.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 65.34 | 162,371.0 |
| CIPLA LTD | 4,544.70 | 23.86 | 108,441.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 63.19 | 135,229.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.32 | 106,407.0 |
| MANKIND PHARMA LTD | 1,796.65 | 47.85 | 85,977.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.83 | 92,885.5 |
| LUPIN LTD | 4,347.53 | 23.11 | 100,485.0 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.24 | 69,768.8 |
| ABBOTT INDIA LTD | 1,508.95 | 38.70 | 58,389.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PARNAX LAB 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 12.90x |
| Max industry PE | 65.34x |
| Median industry PE | 23.86x |
| Average industry PE | 33.68x |
You may also like the below Video Courses